Svante Zipfel

1.0k total citations
16 papers, 409 citations indexed

About

Svante Zipfel is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Immunology. According to data from OpenAlex, Svante Zipfel has authored 16 papers receiving a total of 409 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 8 papers in Cardiology and Cardiovascular Medicine and 5 papers in Immunology. Recurrent topics in Svante Zipfel's work include Cardiac and Coronary Surgery Techniques (5 papers), Complement system in diseases (4 papers) and Mechanical Circulatory Support Devices (4 papers). Svante Zipfel is often cited by papers focused on Cardiac and Coronary Surgery Techniques (5 papers), Complement system in diseases (4 papers) and Mechanical Circulatory Support Devices (4 papers). Svante Zipfel collaborates with scholars based in Germany, Canada and Sweden. Svante Zipfel's co-authors include Christine Skerka, Peter F. Zipfel, Heiko Richter, Stefan Heinen, Stefanie Reuter, Christoph Licht, Mihály Józsi, Hermann Reichenspurner, Luke D. Halder and Evaldas Girdauskas and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Svante Zipfel

12 papers receiving 403 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Svante Zipfel Germany 7 313 181 155 46 45 16 409
Christopher M. Bearden United States 9 165 0.5× 105 0.6× 62 0.4× 176 3.8× 51 1.1× 9 504
Despina Mallouri Greece 12 164 0.5× 70 0.4× 190 1.2× 20 0.4× 73 1.6× 34 375
Asimina Fylaktou Greece 10 95 0.3× 69 0.4× 24 0.2× 48 1.0× 17 0.4× 56 288
M. Gokel Germany 7 195 0.6× 125 0.7× 30 0.2× 214 4.7× 17 0.4× 25 499
C. Erik Hack Netherlands 9 174 0.6× 19 0.1× 107 0.7× 67 1.5× 119 2.6× 9 414
Anne Fuller United States 11 268 0.9× 52 0.3× 42 0.3× 120 2.6× 8 0.2× 13 446
Utako Kaneko Japan 11 149 0.5× 33 0.2× 98 0.6× 67 1.5× 10 0.2× 29 334
H H Yang United States 7 103 0.3× 21 0.1× 202 1.3× 32 0.7× 38 0.8× 8 339
W. M. Baldwin United States 9 146 0.5× 22 0.1× 36 0.2× 205 4.5× 13 0.3× 29 388
Gonca E. Karahan Netherlands 14 182 0.6× 113 0.6× 24 0.2× 147 3.2× 9 0.2× 34 475

Countries citing papers authored by Svante Zipfel

Since Specialization
Citations

This map shows the geographic impact of Svante Zipfel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Svante Zipfel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Svante Zipfel more than expected).

Fields of papers citing papers by Svante Zipfel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Svante Zipfel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Svante Zipfel. The network helps show where Svante Zipfel may publish in the future.

Co-authorship network of co-authors of Svante Zipfel

This figure shows the co-authorship network connecting the top 25 collaborators of Svante Zipfel. A scholar is included among the top collaborators of Svante Zipfel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Svante Zipfel. Svante Zipfel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Philipp, Sebastian, B. Reiter, Svante Zipfel, et al.. (2025). Gender related outcome differences in off-pump coronary artery bypass grafting. Frontiers in Cardiovascular Medicine. 12. 1641784–1641784.
2.
Schneeberger, Y., Martin K. Beyer, Xiaoqin Hua, et al.. (2025). Coronary artery bypass grafting using both internal mammary arteries—a safe concept for surgical training. Interdisciplinary CardioVascular and Thoracic Surgery. 40(5).
3.
Schaefer, Andreas, B. Reiter, Svante Zipfel, et al.. (2024). Utilization of Vein Grafts in Coronary Artery Bypass Grafting: Reasons and Outcomes in a Bilateral Mammary Artery First Center. Journal of Cardiac Surgery. 2024(1). 1 indexed citations
4.
Hartmann, Andrea, Svante Zipfel, Marc Thilo Figge, et al.. (2024). Unique target binding by the C-terminal region of FHR1 provides a new perception of aHUS pathology. SHILAP Revista de lepidopterología. 3. 2 indexed citations
5.
Schaefer, Andreas, B. Reiter, Shiho Naito, et al.. (2024). Association of HbA1c and utilization of internal mammary arteries with wound infections in CABG. Frontiers in Cardiovascular Medicine. 11. 1345726–1345726.
6.
Petersen, Johannes, Shiho Naito, Simon Pecha, et al.. (2022). Antegrade axillary arterial perfusion in 3D endoscopic minimally-invasive mitral valve surgery. Frontiers in Cardiovascular Medicine. 9. 980074–980074. 7 indexed citations
7.
Garnier, Anne, Nadja I. Bork, Eric Jacquet, et al.. (2021). Mapping genetic changes in the cAMP-signaling cascade in human atria. Journal of Molecular and Cellular Cardiology. 155. 10–20. 11 indexed citations
8.
Skerka, Christine, Gabriele Pradel, Luke D. Halder, et al.. (2020). Factor H‐related protein 1: a complement regulatory protein and guardian of necrotic‐type surfaces. British Journal of Pharmacology. 178(14). 2823–2831. 14 indexed citations
9.
Castro, Liesa, Svante Zipfel, Andreas Schaefer, et al.. (2020). Switching to Impella 5.0 decreases need for transfusion in patients undergoing temporary mechanical circulatory support. Journal of Critical Care. 57. 253–258. 8 indexed citations
10.
Irmscher, Sarah, Silke R. Brix, Svante Zipfel, et al.. (2019). Serum FHR1 binding to necrotic-type cells activates monocytic inflammasome and marks necrotic sites in vasculopathies. Nature Communications. 10(1). 2961–2961. 49 indexed citations
11.
Bernhardt, A., Svante Zipfel, B. Reiter, et al.. (2019). Impella 5.0 therapy as a bridge-to-decision option for patients on extracorporeal life support with unclear neurological outcomes. European Journal of Cardio-Thoracic Surgery. 56(6). 1031–1036. 23 indexed citations
12.
Zipfel, Svante, B. Reiter, B. Sill, et al.. (2018). Levosimendan Effects Benefit Weaning from Veno-Arterial Extracorporeal Life Support. The Thoracic and Cardiovascular Surgeon. 66(S 01). S1–S110. 3 indexed citations
13.
Zipfel, Svante, B. Reiter, Markus J. Barten, et al.. (2018). Levosimendan Effects Benefit Weaning From Veno-Arterial Extracorporeal Life Support. The Journal of Heart and Lung Transplantation. 37(4). S383–S383. 6 indexed citations
14.
Linder, Matthias, Simon Pecha, Svante Zipfel, et al.. (2016). Lead Extraction with High-Frequency Laser Sheaths: A Single-Center Experience. The Thoracic and Cardiovascular Surgeon. 64(S 01). 1 indexed citations
15.
Józsi, Mihály, Stefanie Reuter, Svante Zipfel, et al.. (2007). Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency and affect recognition functions. Molecular Immunology. 44(16). 3924–3924. 5 indexed citations
16.
Józsi, Mihály, Christoph Licht, Stefanie Reuter, et al.. (2007). Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency. Blood. 111(3). 1512–1514. 279 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026